ArticleInternational journal of molecular sciences2021

Gemcitabine-Based Chemoradiotherapy Enhanced by a PARP Inhibitor in Pancreatic Cancer Cell Lines.

Waisse Waissi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.